Nature`s Sunshine Products Overview
Nature`s Sunshine Products (NATR) has a ROE of 10.69%, below the Healthcare sector average of 22.01%.
Get informed when a big investor buys or sells
+ Follow10.69%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Nature`s Sunshine Products's return on equity stands at 10.69%. That is below the Healthcare sector average of 22.01%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Nature`s Sunshine Products sits lower the Healthcare benchmark (22.01%) with a ROE of 10.69%. That is roughly 51.4% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of 10.69% for Nature`s Sunshine Products means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Nature`s Sunshine Products's ROE evolved across reporting periods, while the comparison chart places NATR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, ROE is commonly used to spot outliers. Nature`s Sunshine Products's reading of 10.69% (sector avg 22.01%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
